Study identifies Covid-19 patients with mutations indicating remdesivir resistance

As the bivalent booster season kicks off in earnest, a new study published yesterday from NYU researchers identifies two cases of mutated coronavirus resistant to Gilead’s remdesivir in immunocompromised individuals.